EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma

Ling-Yu Chu, Fang-Cai Wu, Wang-Kai Fang, Chao-Qun Hong, Li-Sheng Huang, Hai-Ying Zou, Yu-Hui Peng, Hao Chen, Jian-Jun Xie, Yi-Wei Xu

Biomedical Journal · 2024

DOI: 10.1016/j.bj.2023.100662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Journal, 2024. Verfasst von Ling-Yu Chu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, China; Department of Biochemistry and Mol…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Biomarkers, Tumor, Esophageal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Early detection of cancer remains an unmet need in clinical practice, and high diagnostic sensitivity and specificity biomarkers are urgently required. Here, we attempted to identify secreted proteins encoded by super-enhancer (SE)-driven genes as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC). METHODS: We conducted an integrative analysis of multiple data sets including ChIP-seq data, secretome data, CCLE data and GEO data to screen secreted proteins encoded by SE-driven genes. Using ELISA, we further identified up-regulated secreted proteins through a small size of clinical samples and verified in a multi-centre validation stage (345 in test cohort and 231 in validation cohort). Receiver operating characteristic curves were used to calculate diagnostic accuracy. Artificial intelligence (AI) method named gradient boosting machine (GBM) were applied for model construction to enhance diagnostic accuracy. RESULTS: Serum EFNA1 and MMP13 were identified, and showed significantly higher levels in ESCC patients compared to normal controls. An integrated Five-Biomarker Panel (iFBPanel) established by combining EFNA1, MMP13, carcino-embryonic antigen, Cyfra21-1 and squmaous cell carcinoma antigen had AUCs of 0.881 and 0.880 for ESCC in test and validation cohorts, respectively. Importantly, the iFBPanel also exhibited good performance in detecting early-stage ESCC patients (0.872 and 0.864). Furthermore, the iFBPanel was further empowered by AI technology which showed excellent diagnostic performance in early-stage ESCC (0.927 and 0.907). CONCLUSIONS: Our study suggested that serum EFNA1 and MMP13 could potentially assist ESCC detection, and provided an easy-to-use detection model that might help the diagnosis of early-stage ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaBiomarkers, TumorEsophageal NeoplasmsEarly Detection of CancerHumansFemaleMaleMiddle AgedEnhancer Elements, GeneticAgedSuper Enhancers

Stichwörter der Autor:innen

EFNA1Early diagnosisEsophageal squamous cell carcinomaMMP13Super-enhancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, China; Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, China.
  • Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shanto, China; Guangdong Esophageal Cancer Institute, Cancer Hospital of Shantou University Medical College, Shanto, China; Esopha…
  • Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, China.
  • Department of Oncological Laboratory Research, Cancer Hospital of Shantou University Medical College, Shantou, China.
  • Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shanto, China.
  • Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, China; Guangdong Esophageal Cancer Institute, Cancer Hospital of Shantou University Medical College, Shanto, Ch…

Zitieren

APA

Chu, L. Y., Wu, F. C., Fang, W. K., Hong, C. Q., Huang, L. S., Zou, H. Y., Peng, Y. H., Chen, H., Xie, J. J., & Xu, Y. W. (2024). Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma. Biomedical Journal. https://doi.org/10.1016/j.bj.2023.100662

Vancouver

Chu LY, Wu FC, Fang WK, Hong CQ, Huang LS, Zou HY, et al. Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma. Biomedical Journal. 2024. doi:10.1016/j.bj.2023.100662

BibTeX
@article{Chu2024,
  author = {Chu, Ling-Yu and Wu, Fang-Cai and Fang, Wang-Kai and Hong, Chao-Qun and Huang, Li-Sheng and Zou, Hai-Ying and Peng, Yu-Hui and Chen, Hao and Xie, Jian-Jun and Xu, Yi-Wei},
  title = {Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma},
  journal = {Biomedical Journal},
  year = {2024},
  doi = {10.1016/j.bj.2023.100662}
}
Kostenlos starten →